Product Images Brevibloc
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Brevibloc NDC 10019-670 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Medication Port can be used for withdrawing initial bolus only. The text is not complete and clear.*
This is a description of a medication called Breviblog Premixed Injection which is a product containing Esmolol Hydrochloride and sodium chloride. It is a sterile and nonpyrogenic solution that is for single intravenous use only. The usual dosage should be checked from the package insert. The solution should be clear colorless to light-yellow. The container should be checked for leaks before using the solution, and it should be discarded if leakage is found. The solution must not be used in series connections. The medication is manufactured by Intravia Container, a subsidiary of Baxter.*
This is a product description for Brevibloc Premixed Injection - Esmolol Hydrochloride in Sodium Chloride. The product comes in 10 250 mL single-use Intravia containers, each containing 2,500 mg/250 mL (10 mg/m). It has to be stored at 25°C (77°F) and protected from freezing. The barcode needs to be placed by the manufacturer. The provided NDC is 10019-670-10.*
This is a description of a medication called Brevibloc manufactured by Baxter in the USA. It is a premixed double-strength injection containing 2,000 mg/100 mL of Esmolol Hydrochloride in Sodium Chloride. It is for single intravenous use only and contains no preservatives. The acidity of the solution is pH 5.0. The container should be checked for leaks before use, and if any leaks are found, the container should be discarded. Only use the medication if the solution is clear and colorless to light yellow. It should not be stored at temperatures below freezing and should not be used in series connections. The dosage details are not available in the text provided.*
The text describes BREVIBLOC PREMIXED injection solution contained separately in 10 100 mL single-use INTRAVIA containers. Each container holds Esmolol Hydrochloride In Sodium Chloride 2,000 mg/100 mL with double strength. It must be stored at temperatures ranging from 10-30°C. The manufacturer is Baxter Healthcare Corporation, and the containers have a unique identification code NDC 10019-666-10. The barcode placement is necessary.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.